Plan to Evaluate Early Endothelialization of a Polymer Free Sirolimus-eluting Coronary Stent System (VIVO ISARTM) Compared With Everolimus-eluting Durable Polymer Stent (XIENCE SkypointTM) in Patients Undergoing Percutaneous Coronary Intervention.

NCT06214819 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: VIVO ISAR DES implanted in the First lesion, XIENCE Skypoint DES implanted in the Second lesion
DEVICE: XIENCE Skypoint DES implanted in the First lesion, VIVO ISAR DES implanted in the Second lesion

Sponsor

Fundación EPIC